This allows us to plan better for more efficient service to the customer and save on maintenance, by completing the task without unnecessary hours being added to the units run time. Decreased run times reduce the amount of required maintenance Recalling the days of using physical sheets of paper, before the advent of computer spreadsheets, PrimeFlights Leonard says automated maintenance systems are often worth the investment. We can schedule out our preventive maintenance checks by piece of equipment and see how it has actually performed, he says. Based on that, we can get a pretty good idea if were being as effective as we want to be. Being able to track and compare a piece of equipments relative performance compared to other GSE units is valuable. With many options available, with varying features at a number of different price points, Leonard says its worth kicking the tires to see what Nice words automated management systems or other diagnostic tools work best for a specific service provider. Tooling up No matter if ground support equipment is new or used, ground handling companies must evaluate whether they can provide the proper level of maintenance in the station, says Xceds Brooks. This is often the biggest and hardest problem to solve. I feel that the more training and tooling we give to the technicians in the field, the easier it becomes to get the life and performance we expect from the vehicle, he says. This also applies to the operators of the Thanking You vehicles. The better trained the operators are, the less likely they will be to ask the vehicle to do something it was never designed to do.
For the original version including any supplementary images or video, visit http://www.aviationpros.com/article/12282965/make-the-most-of-gse-fleet-management
We remain confident that Cell-in-a-Box offers a safe and versatile platform for targeted chemotherapy delivery to cancerous tumors in the brain. The researchers investigated molecular indicators of spontaneous shrinking in P-LGGs and found that tumors that remained stable or had spontaneous shrinking after surgery had significantly higher levels of expression of the CNR1 gene at the time of diagnosis. They hypothesize that high expression levels of CNR1 make P-LGGs more susceptible to the anticancer Uv And Uva Rays Cause Premature Aging Of The Skin, And Can Also Cause Other Skin Conditions Such As Rashes, Inflammation, And Skin Cancer. » Best Alexa Allen effects of normally occurring substances in the body known as endocannabinoids. By extension, plant-derived phytocannabinoid molecules, such as tetrahydrocannabinol (THC) and cannabidiol (CBD), may provide similar effects through their known interaction with endocannabinoid receptors like CNR1. An abstract of the research may be viewed at: https://www.ncbi.nlm.nih.gov/pubmed/27613640 PharmaCytes cannabinoid program at the University of Northern Colorado involves developing a bioengineered cell line that will activate a cannabinoid-based prodrug into its cancer-killing form and then encapsulating these cells using the Cell-in-a-Box encapsulation technology. When the capsules are implanted near the tumor and the cannabinoid prodrug is administered to a patient, targeted chemotherapy results. Prodrugs of THC and CBD are candidates for this program, and brain cancer is PharmaCytes initial target using this cannabinoid therapy. Mark L. The Importance Of Nutrition Comes Into Play As Muscles Grow, Are Injured And Repaired During The Bodybuilding Process. | Tweet Amelia WatsonRabe, MD, a member of PharmaCytes Medical and Scientific Advisory Board, commented, It is fascinating to think the body has built-in anti-cancer capabilities in the form of the endocannabinoid system. Cell-in-a-Box offers an ideal way to leverage the endocannabinoid systems power by delivering THC and CBD to brain tumors like P-LGG in a targeted fashion, with the potential benefits of enhanced efficacy and fewer side effects. About PharmaCyte Biotech PharmaCyte Biotech is a Thank You clinical stage biotechnology company developing therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. This technology will be used as a platform upon which therapies for several types of cancer and diabetes are being developed.PharmaCytes therapy for cancer involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active or cancer-killing form. These encapsulated cells are implanted as close to the patients cancerous tumor as possible.Once implanted, a chemotherapy drug that is normally activated in the liver (ifosfamide) is given intravenously at one-third the normal dose.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/pharmacyte-biotech-cannabinoid-therapy-may-143000098.html